Wayne Bond Lau Selected Research

Interleukin-6 (Interleukin 6)

1/2019

Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wayne Bond Lau Research Topics

Disease

20	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 02/2009
16	Reperfusion Injury 01/2020 - 02/2009
13	Infarction (Infarctions) 01/2020 - 03/2009
10	Myocardial Infarction 01/2021 - 02/2009
10	Neoplasms (Cancer) 01/2020 - 05/2015
8	Heart Failure 11/2023 - 07/2011
6	Hypoxia (Hypoxemia) 01/2022 - 12/2011
5	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
5	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2016
5	Obesity 06/2017 - 09/2010
4	Insulin Resistance 11/2023 - 10/2010
4	Fibrosis (Cirrhosis) 09/2020 - 01/2015
4	Ischemia 10/2018 - 03/2009
3	Heart Injuries 01/2020 - 02/2009
3	Atherosclerosis 01/2017 - 10/2011
3	Poisoning 07/2016 - 04/2014
3	Pre-Eclampsia (Preeclampsia) 05/2015 - 09/2012
2	Vascular System Injuries 06/2022 - 09/2010
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2017
2	Cardiomegaly (Heart Hypertrophy) 12/2020 - 07/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 12/2011
2	Inflammation (Inflammations) 01/2019 - 12/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2017 - 10/2011
2	Colorectal Neoplasms (Colorectal Cancer) 02/2017 - 05/2015
2	Type 2 Diabetes Mellitus (MODY) 08/2015 - 12/2011
2	Vascular Ring 03/2014 - 03/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2012 - 10/2010
2	Wounds and Injuries (Trauma) 08/2011 - 05/2011
1	Diabetic Angiopathies (Diabetic Angiopathy) 12/2023
1	Hypoadiponectinemia 12/2023
1	Prediabetic State (Prediabetes) 11/2023
1	Ischemic Stroke 11/2022
1	Cardiotoxicity 09/2020
1	Obstructive Sleep Apnea 01/2020
1	Carcinoma (Carcinomatosis) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018

Drug/Important Bio-Agent (IBA)

21	AdiponectinIBA 12/2023 - 02/2009
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2010
5	Insulin (Novolin)FDA Link 11/2023 - 10/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Caveolin 3IBA 11/2023 - 04/2012
4	Caspase 3 (Caspase-3)IBA 01/2021 - 02/2009
4	CytokinesIBA 01/2019 - 06/2013
4	AMP-Activated Protein KinasesIBA 01/2019 - 02/2009
4	AutoantibodiesIBA 01/2019 - 09/2012
4	AdipokinesIBA 06/2017 - 08/2011
3	Adiponectin ReceptorsIBA 01/2022 - 09/2011
3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 09/2009
3	ParaquatIBA 07/2016 - 01/2015
3	Type 1 Angiotensin ReceptorIBA 05/2015 - 09/2012
3	Glucose (Dextrose)FDA LinkGeneric 07/2014 - 07/2009
3	Superoxides (Superoxide)IBA 01/2013 - 03/2009
2	Protein Isoforms (Isoforms)IBA 11/2022 - 01/2015
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 09/2013
2	CateninsIBA 01/2020 - 01/2020
2	withaferin AIBA 01/2019 - 10/2018
2	Anesthetics (Anesthetic Agents)IBA 01/2019 - 09/2013
2	RNA (Ribonucleic Acid)IBA 01/2018 - 02/2017
2	Long Noncoding RNAIBA 02/2017 - 01/2017
2	AdipoRonIBA 01/2017 - 08/2015
2	EnzymesIBA 01/2017 - 11/2016
2	Triglycerides (Triacylglycerol)IBA 11/2016 - 09/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 03/2009
2	IntegrinsIBA 01/2016 - 09/2009
2	Messenger RNA (mRNA)IBA 01/2015 - 12/2011
2	Peroxidase (Myeloperoxidase)IBA 07/2014 - 02/2009
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2013 - 01/2013
2	Lymphotoxin-alpha (Lymphotoxin)IBA 03/2013 - 01/2013
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2013 - 03/2009
2	ThioredoxinsIBA 09/2010 - 07/2009
1	PhosphotyrosineIBA 12/2023
1	Inhibitor of Apoptosis ProteinsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	CaspasesIBA 01/2021
1	Nicotine FDA Link 09/2020
1	salicylhydroxamic acid (SHAM)IBA 09/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	CM-DiIIBA 01/2020
1	H-cadherin (T-cadherin)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	CatecholaminesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2018
1	erteberelIBA 01/2018
1	AcetyltransferasesIBA 01/2018
1	DisulfidesIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	Untranslated Regions (Untranslated Region)IBA 01/2018
1	CalreticulinIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Estrogen Receptor betaIBA 01/2018

Therapy/Procedure

8	Therapeutics 01/2022 - 08/2013
2	Ligation 01/2013 - 09/2010